Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Dynamo claims to be the world's only 100% electric zero-emissions London black cab. It asserts that it uses Nissan's fully electric eNV200 Evalia MPV as a donor vehicle and converts it to a fully certified and compliant London 'Black Cab'. Dynamo argues that there are nearly 70,000 taxis in the UK, of which 4,000 have already converted to electric vehicles. Dynamo is competing to convert the remaining 66,000 into electric ones to gain profit and improve the environment. Dynamo has, to date, sold 170 vehicles in London, Liverpool, Coventry, Sheffield, and Nottingham. The company intends to become a competitor in the £4 billion taxi market. It states it will use the investment to procure a vast array of additional parts and equipment from a localised supply chain, increase its workforce, develop a second product in collaboration with Nissan/Renault Alliance, and strengthen its relationship with large automotive manufacturers.
days to go:
Expired
investment:
£1,768,035
This Mum Runs (TMR) aims to get more women running. They currently have a 4,000 person strong community, nearly 3,000 mums running and over 30% of those are paying for TMR's courses. This Mum Runs offer over 50 runs a month in Bristol and Bath alone and are looking to expand to other cities by the end of the year.
days to go:
Expired
investment:
£103,230
Creating grand design homes in a factory that are high-tech, spacious and environmentally friendly. nHouse's modernised construction process means that less time can be spent building a home which has resulted in an increased production output and therefore greater efficiency. A nHouse modular home can be constructed within 12 to 16 weeks and they have already received more than 500 sales enquiries. The company has also attained BOPAS accreditation from the Council of Mortgage Lenders to reassure home insurers and mortgage providers.
days to go:
Expired
investment:
£307,170
Bricksave is a global platform that provides individuals with direct access to institutional-grade real estate investments previously only accessible to experienced, qualified, High Net Worth Investors. The company has a fully automated and functioning platform through which it hit the target of $4m and is aiming for the next milestone of $25m by the end of 2020. Moreover, the company has an experienced founding team of advisors backed by a successful track record. It also received a YoY growth in excess of 260%. With the proceeds, Bricksave will continue its aggressive growth strategy, boost its market position in current geographies and increase marketing efforts.
days to go:
Expired
investment:
£673,025
One Woman Driver is an online market place that allows consumers to buy used cars formally owned by women drivers. The investment will be used to fund fast growth and a mobile app.
(EIS Pending and SEIS Pending)
days to go:
Expired
investment:
£416,770
GalleriesNow is a revolutionary art platform rapidly becoming the most trusted source of information on galleries, artists and exhibitions worldwide. We have achieved tremendous traction in the space of one year, already working with Frieze Art Fair, Soho House and the FT and in discussions with major arts publications - and are an increasingly valuable way for galleries to interact with their audiences. We are fundraising to consolidate and bring further revenue streams on-line. Our goal is to be the perfect bridge between gallery and art buyer - join us on our journey!
days to go:
Expired
investment:
£33,384
